Welcome to our dedicated page for Applied UV news (Ticker: AUVI), a resource for investors and traders seeking the latest updates and insights on Applied UV stock.
Applied UV, Inc. (AUVI) delivers innovative UV-based disinfection systems and custom mirror solutions for healthcare and hospitality sectors. This page provides investors and industry professionals with direct access to official announcements, financial updates, and strategic developments from the company.
Find timely updates on product launches, regulatory milestones, and partnership agreements that shape AUVI’s position in smart building technology and infection control markets. Content includes earnings reports, technology patents, and market expansion initiatives, offering insights into the company’s operational priorities.
Bookmark this page to stay informed about AUVI’s advancements in automated sterilization systems and decorative mirror designs. Regular updates ensure you never miss critical information affecting the company’s performance across global healthcare and hospitality markets.
Applied UV, Inc. (NASDAQ:AUVI) announced the complete exercise of an over-allotment option for its Series A Preferred Stock, resulting in the sale of an additional 72,000 shares at $25.00 each, generating $1.8 million. This brings total gross proceeds from the offering to $13.8 million for 552,000 shares. The company aims to use proceeds for general corporate purposes, including investments and acquisitions. The Series A Preferred Stock began trading on July 14, 2021, under the ticker symbol AUVIP.
Applied UV (NASDAQ: AUVI) has authorized a cash dividend of $0.21875 per share for holders of its 10.5% Series A Cumulative Perpetual Preferred Stock (NASDAQ: AUVIP). This dividend will be paid on or about August 16, 2021, to shareholders on record as of August 4, 2021. The company focuses on infection control technology, utilizing UVC light for disinfecting surfaces and air purification through its proprietary technologies, including Airocide and Lumicide.
Applied UV, Inc. (NASDAQ:AUVI) announced the installation of additional Airocide® units at Lat Krabang Hospital in Bangkok, enhancing infection control measures amidst the ongoing fight against COVID-19. The hospital now uses a total of 15 Airocide systems, which utilize UVC technology to eliminate airborne pathogens. This installation reflects Thailand's commitment to advancing air purification technology in healthcare. Applied UV aims to strengthen distributor relationships in Southeast Asia to meet increasing demand for infection control products.
Applied UV (NasdaqCM: AUVI) has entered an exclusive distribution agreement with Lootah Batta Water and Environment for its Airocide® air purification systems in the UAE. This partnership leverages LBWE's experience and market familiarity to expand the reach of Airocide products across various sectors, including healthcare and hospitality. The Airocide® system, developed by NASA, is clinically proven to eliminate airborne pathogens and harmful substances.
Applied UV (NASDAQ:AUVI) has successfully closed its public offering of 480,000 shares of 10.5% Series A Cumulative Perpetual Preferred Stock, raising $12.0 million in gross proceeds. Each share has a liquidation preference of $25.00. The company has granted underwriters a 45-day option for an additional 72,000 shares. Proceeds will fund a segregated dividend account for the first 12 monthly dividends and support general corporate purposes, including investments and acquisitions. The shares are expected to trade under the symbol AUVIP starting July 20, 2021.
Applied UV (NASDAQ:AUVI) announced the installation of its Airocide® air purification units at the Palace of Versailles, enhancing pathogen control and protecting valuable art.
The units utilize a patented photocatalytic oxidation process to eliminate harmful microorganisms, ensuring a safer environment for staff and preserving artworks.
This installation reflects the efficacy of Airocide® technology in demanding settings like museums, highlighting its extensive applications in various industries.
Applied UV (NASDAQ:AUVI) has successfully priced its public offering of 480,000 shares of 10.5% Series A Cumulative Perpetual Preferred Stock at $25.00 per share, aiming to raise $12.0 million before expenses. The offering is set to close around July 16, 2021. The company plans to use the proceeds for funding a segregated dividend account and for general corporate purposes, including potential acquisitions. An additional 72,000 shares may be purchased by underwriters within 45 days. Trading of the shares on Nasdaq is anticipated to begin on July 20, 2021.
Applied UV, Inc. (NASDAQ: AUVI) will present at the Ladenburg Thalmann Virtual Healthcare Conference on July 14, 2021, at 12:30 PM ET. The company specializes in infection control technology using narrow-range ultraviolet light (UVC) for surface disinfection and air purification. Their products, including the Lumicide platform and Airocide air purification system, target healthcare and commercial sectors to eliminate pathogens and improve safety. A live webcast of the presentation can be viewed here, with a replay available on their website.
Applied UV has successfully installed its Airocide® air purification technology at Verbier International School in Switzerland. This initiative aims to enhance safety for students and staff amidst ongoing health concerns. The installation serves as a prototype for further expansion of Airocide into European schools. CEO Q Saeed emphasized that this technology offers a clinically proven solution for air pathogen control, crucial for ensuring a safe return to campus as schools prepare for the new academic year.
Applied UV, Inc. (NasdaqCM:AUVI) has announced a public offering of 10.5% Series A Cumulative Perpetual Preferred Stock. The company aims to use the proceeds to fund a segregated dividend account for the first year of dividend payments and for general corporate purposes, including potential investments and acquisitions. The offering is subject to market conditions, and there's no guarantee on its completion. Ladenburg Thalmann & Co. Inc. is the lead manager for the offering.
FAQ
What is the current stock price of Applied UV (AUVI)?
What is the market cap of Applied UV (AUVI)?
